Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Summary

Subjects will be randomly assigned to one of 3 treatment groups and receive 325 mg (65 mg elemental iron) iron supplements twice daily.

Timeline

Start

2008-10

Primary completion

2009-08

Completion

2009-08

Outcome

Outcome not reported

Stopped: “Repros stopped the study for safety and FDA put the study on hold for safety.”

Drugs

Indications